IAS
Investment Advisory Services’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.81M | Buy |
25,895
+907
| +4% | +$168K | 1.6% | 14 |
|
|
2025
Q1 | $5.24M | Sell |
24,988
-833
| -3% | -$175K | 1.89% | 12 |
|
|
2024
Q4 | $4.59M | Sell |
25,821
-2,689
| -9% | -$478K | 1.62% | 14 |
|
|
2024
Q3 | $5.63M | Sell |
28,510
-1,887
| -6% | -$373K | 1.99% | 10 |
|
|
2024
Q2 | $5.21M | Sell |
30,397
-992
| -3% | -$170K | 1.91% | 10 |
|
|
2024
Q1 | $5.72M | Sell |
31,389
-347
| -1% | -$63.2K | 2.1% | 10 |
|
|
2023
Q4 | $4.92M | Sell |
31,736
-215
| -0.7% | -$33.3K | 1.94% | 12 |
|
|
2023
Q3 | $4.76M | Buy |
31,951
+25
| +0.1% | +$3.73K | 2.05% | 12 |
|
|
2023
Q2 | $4.3M | Buy |
31,926
+4
| +0% | +$539 | 1.82% | 11 |
|
|
2023
Q1 | $5.09M | Sell |
31,922
-241
| -0.7% | -$38.4K | 2.51% | 11 |
|
|
2022
Q4 | $5.22M | Buy |
32,163
+127
| +0.4% | +$20.6K | 2.68% | 9 |
|
|
2022
Q3 | $4.3M | Buy |
32,036
+40
| +0.1% | +$5.37K | 2.57% | 11 |
|
|
2022
Q2 | $4.9M | Sell |
31,996
-641
| -2% | -$98.2K | 2.83% | 7 |
|
|
2022
Q1 | $5.29M | Buy |
32,637
+103
| +0.3% | +$16.7K | 2.95% | 6 |
|
|
2021
Q4 | $4.41M | Buy |
32,534
+461
| +1% | +$62.4K | 2.4% | 8 |
|
|
2021
Q3 | $3.46M | Sell |
32,073
-54
| -0.2% | -$5.83K | 2.12% | 8 |
|
|
2021
Q2 | $3.62M | Buy |
+32,127
| New | +$3.62M | 2.23% | 8 |
|
|
2020
Q4 | $3.53M | Sell |
32,941
-46
| -0.1% | -$4.93K | 2.47% | 7 |
|
|
2020
Q3 | $2.89M | Buy |
32,987
+102
| +0.3% | +$8.93K | 2.28% | 9 |
|
|
2020
Q2 | $3.23M | Buy |
32,885
+2,660
| +9% | +$261K | 2.76% | 8 |
|
|
2020
Q1 | $2.3M | Buy |
30,225
+1,668
| +6% | +$127K | 2.47% | 9 |
|
|
2019
Q4 | $2.53M | Buy |
+28,557
| New | +$2.53M | 2.27% | 10 |
|